TELA Bio (TELA) to Release Quarterly Earnings on Thursday

TELA Bio (NASDAQ:TELA) is expected to release its earnings data after the market closes on Thursday, March 20th. Analysts expect TELA Bio to post earnings of ($0.24) per share and revenue of $23.17 million for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

TELA Bio Stock Down 3.3 %

TELA stock opened at $2.35 on Wednesday. The firm has a 50 day moving average of $2.61 and a 200 day moving average of $2.72. The stock has a market capitalization of $92.56 million, a PE ratio of -1.39 and a beta of 1.10. The company has a quick ratio of 1.81, a current ratio of 2.62 and a debt-to-equity ratio of 14.22. TELA Bio has a 52 week low of $2.18 and a 52 week high of $6.50.

TELA Bio Company Profile

TELA Bio, Inc, a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs.